S. E. Evstifeeva
S. E. Evstifeeva has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
- A. V. Kapustina
National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health of the Russian Federation
2 shared publications - Andrey Nikolaevich Redko
Kuban State Medical University
2 shared publications - Anna G. Soplenkova
M.V. Lomonosov Moscow State University; National Medical Research Center for Therapy and Preventive Medicine, Ministry of Health of Russia
2 shared publications - Asiia E. Imaeva
National Medical Research Centre for Therapy and Preventive Medicine, Ministry of Health of Russia
2 shared publications - Elena M. Filichkina
Lomonosov Moscow State University
2 shared publications - Galina A. Muromtseva
National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health of the Russian Federation
2 shared publications
Latest Publications
- Open Access
- 8 February 2026
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (12) , 4589
Fatty liver index as a predictor of fatal and non-fatal cardiovascular events in Russians: analysis of an epidemiological cohort
Aim. To study the associations of a high fatty liver index (FLI ≥60) with the risk of death and nonfatal cardiovascular events in a Russian epidemiological cohort. Material and methods. The analysis included data from ESSE-RF2 epidemiological study. FLI was calculated using the Bedogni G et al. equation (2006). A high FLI ≥60 was considered a predictor of liver steatosis. A total of 5381 individuals aged 25-64 years from 4 Russian regions (the Republic of Karelia, Krasnodar Krai, Omsk and Ryazan Oblasts) were included, of which 1672 had FLI ≥60. Fatal endpoints included all-cause (ACD) and cardiovascular death (CVD), while nonfatal endpoints included myocardial infarction (MI), cerebrovascular accident (CVA), heart failure progression (hospitalization), and revascularization. The composite endpoint (CE) included cardiovascular death or a non-fatal endpoint. Statistical analysis was performed using the R language and environment (version 4.2). The significance level for all tested hypotheses was pResults. Kaplan-Meier survival curve analysis showed that the group of patients with a FLI ≥60 had significantly worse survival outcomes compared to the group with an FLI Conclusion. In the group of individuals with a FLI ≥60, survival rates were significantly lower than in the group with a FLI <30 for all studied outcomes (ACD, CVD, and CE). In a univariate Cox regression model adjusted for region, a high FLI was associated with non-fatal CVA, ACD, CVD, and CE. However, in a multivariable model (adjusted for region, age, sex, lifestyle factors, and lipid metabolism disorders), a significant association of FLI ≥60 remained only with CE.
- 8 February 2026
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (12) , 4589
Open AccessFatty liver index as a predictor of fatal and non-fatal cardiovascular events in Russians: analysis of an epidemiological cohort
Aim. To study the associations of a high fatty liver index (FLI ≥60) with the risk of death and nonfatal cardiovascular events in a Russian epidemiological cohort. Material and methods. The analysis included data from ESSE-RF2 epidemiological study. FLI was calculated using the Bedogni G et al. equation (2006). A high FLI ≥60 was considered a predictor of liver steatosis. A total of 5381 individuals aged 25-64 years from 4 Russian regions (the Republic of Karelia, Krasnodar Krai, Omsk and Ryazan Oblasts) were included, of which 1672 had FLI ≥60. Fatal endpoints included all-cause (ACD) and cardiovascular death (CVD), while nonfatal endpoints included myocardial infarction (MI), cerebrovascular accident (CVA), heart failure progression (hospitalization), and revascularization. The composite endpoint (CE) included cardiovascular death or a non-fatal endpoint. Statistical analysis was performed using the R language and environment (version 4.2). The significance level for all tested hypotheses was pResults. Kaplan-Meier survival curve analysis showed that the group of patients with a FLI ≥60 had significantly worse survival outcomes compared to the group with an FLI Conclusion. In the group of individuals with a FLI ≥60, survival rates were significantly lower than in the group with a FLI <30 for all studied outcomes (ACD, CVD, and CE). In a univariate Cox regression model adjusted for region, a high FLI was associated with non-fatal CVA, ACD, CVD, and CE. However, in a multivariable model (adjusted for region, age, sex, lifestyle factors, and lipid metabolism disorders), a significant association of FLI ≥60 remained only with CE.
- Open Access
- 8 February 2025
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (2) , 4316
Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular risk factors (data from Russian epidemiological studies)
Aim. To study the prevalence of non-alcoholic fatty liver disease (NAFLD) and its association with cardiovascular risk factors (RFs). Material and methods. The database from the ESSE-RF2 and ESSE-RF3 epidemiological studies was used, including data from surveys of population aged 35-64 years in 18 Russian regions (n=21204). To assess the prevalence of NAFLD, the fatty liver index (FLI) was used. Statistical analysis was performed using the statistical programming language and the R environment (version 3.6.1) with open-source code. The significance level for all tested hypotheses was p≤0,05. Results. Standardized prevalence rates of FLI ≥60 in the ESSE-RF3 study are slightly higher than in the ESSE-RF2 study (39,2% vs 42,3%, respectively). Multivariate analysis adjusted for sex, age, region, settlement type, and education showed significant associations of FLI ≥60 with hypertension, type 2 diabetes, hyperuricemia, lipid metabolism disorders, elevated high-sensitivity C-reactive protein levels, and cerebrovascular accident in men and women. Conclusion. Multivariate analysis confirmed the closest association of NAFLD with hypertension, type 2 diabetes mellitus, metabolic disorders, nonspecific inflammation, dyslipidemia, and cerebrovascular accident in men and women.
- 8 February 2025
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (2) , 4316
Open AccessPrevalence of non-alcoholic fatty liver disease and its association with cardiovascular risk factors (data from Russian epidemiological studies)
Aim. To study the prevalence of non-alcoholic fatty liver disease (NAFLD) and its association with cardiovascular risk factors (RFs). Material and methods. The database from the ESSE-RF2 and ESSE-RF3 epidemiological studies was used, including data from surveys of population aged 35-64 years in 18 Russian regions (n=21204). To assess the prevalence of NAFLD, the fatty liver index (FLI) was used. Statistical analysis was performed using the statistical programming language and the R environment (version 3.6.1) with open-source code. The significance level for all tested hypotheses was p≤0,05. Results. Standardized prevalence rates of FLI ≥60 in the ESSE-RF3 study are slightly higher than in the ESSE-RF2 study (39,2% vs 42,3%, respectively). Multivariate analysis adjusted for sex, age, region, settlement type, and education showed significant associations of FLI ≥60 with hypertension, type 2 diabetes, hyperuricemia, lipid metabolism disorders, elevated high-sensitivity C-reactive protein levels, and cerebrovascular accident in men and women. Conclusion. Multivariate analysis confirmed the closest association of NAFLD with hypertension, type 2 diabetes mellitus, metabolic disorders, nonspecific inflammation, dyslipidemia, and cerebrovascular accident in men and women.